Date published: 2026-1-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

KLHL10 Inhibitors

KLHL10 inhibitors are small molecules designed to target and interfere with the activity of the KLHL10 protein. KLHL10, or Kelch-like family member 10, is part of the larger Kelch-like protein family, characterized by their highly conserved BTB (Bric-a-brac, Tramtrack, Broad Complex) domain, which mediates protein-protein interactions. Additionally, these proteins contain Kelch repeats that form a β-propeller structure, facilitating substrate recognition. KLHL10 is known to function as an adaptor protein within E3 ubiquitin ligase complexes, where it aids in the ubiquitination and subsequent degradation of specific substrates, a key regulatory process for maintaining protein homeostasis. Inhibitors of KLHL10 typically work by binding to this protein, obstructing its interactions within the ubiquitin-proteasome system.

These inhibitors are developed using diverse chemistries, with molecular scaffolds that can interfere with the protein's substrate recognition or its dimerization ability. Structurally, these compounds are optimized to interact with the BTB domain or the Kelch repeats, disrupting the formation of functional complexes necessary for ubiquitination. Many of these inhibitors exhibit specificity by targeting the precise interfaces responsible for KLHL10's protein-protein interactions, avoiding broader effects on other Kelch-like proteins. The design and modification of KLHL10 inhibitors rely heavily on structural biology and computational modeling to refine interactions with the protein's active sites. This high level of specificity allows for a detailed understanding of the role KLHL10 plays in various biological processes. KLHL10 inhibitors are valuable molecular tools in studying the regulation of ubiquitination pathways and protein degradation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitor that stabilizes proteins targeted for degradation; this prevents the degradation of regulatory proteins that control the stability and expression of KLHL10.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

Selective proteasome inhibitor that can increase the levels of regulatory proteins involved in maintaining KLHL10 expression and stability.

Ivermectin

70288-86-7sc-203609
sc-203609A
100 mg
1 g
$57.00
$77.00
2
(2)

Binds to and modulates ion channels; alters cellular ion balance, which can influence signaling pathways regulating KLHL10 expression.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Glycogen synthase kinase-3 (GSK-3) inhibitor; modifies signaling pathways that can stabilize transcription factors regulating KLHL10 gene expression.

SB-216763

280744-09-4sc-200646
sc-200646A
1 mg
5 mg
$71.00
$202.00
18
(1)

GSK-3 inhibitor that can lead to the stabilization of transcription factors implicating in the control of KLHL10 expression.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor that can disrupt the degradation pathways of proteins that regulate KLHL10 expression and stability.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor that alters ERK/MAPK signaling, impacting the post-translational modifications of proteins involved in KLHL10 regulation.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, modifying the JNK signaling pathway which can affect transcription factors and other regulatory proteins that control KLHL10 expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Phosphoinositide 3-kinases (PI3K) inhibitor; affects AKT signaling and can alter the activity of transcription factors that regulate KLHL10.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor that can change the activity of downstream targets involved in the regulation of protein synthesis, including proteins that control KLHL10 expression.